However, the significant finding that the combination of EPLIN, HSP60 and Her2 expression presents a significant independent prognostic indicator for the clinical outcome of the patients strongly argues that this interacting partner group has a value that need to be further explored in this cancer type and potentially in other types of cancers. The gene discussed is ERBB2; the disease is cancer.